OTC Link · Healthcare · Drug Manufacturers - Specialty & Generic
CRESCO LABS INC
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | Q1 2026 | -0.03 | -0.03 | +0.00% | $151.0M | ➖ Inline | — | — | — |
| 2026-03-05 | Q4 2025 | -0.02 | 0.01 | +150.00% | $161.6M | ✅ Beat | — | — | — |
| 2025-11-05 |
| Q3 2025 |
| -0.03 |
| -0.06 |
| -100.00% |
| $164.9M |
| ❌ Miss |
| — |
| — |
| — |
| 2025-03-12 | Q4 2024 | -0.01 | -0.01 | +0.00% | $175.9M | ➖ Inline | -6.04% | -4.03% | -19.46% |
| 2024-11-08 | Q3 2024 | 0.01 | -0.03 | -400.00% | $179.8M | ❌ Miss | — | — | — |
| 2024-05-15 | Q1 2024 | -0.02 | -0.02 | +0.00% | $184.3M | ➖ Inline | +6.22% | -2.87% | -22.49% |
| 2024-03-13 | Q4 2023 | -0.02 | 0.01 | +150.00% | $188.2M | ✅ Beat | — | — | — |
| 2023-11-15 | Q3 2023 | -0.04 | -0.34 | -750.00% | $190.6M | ❌ Miss | — | — | — |
Showing last 8 quarters.